For Media Inquiries, Please Contact:
Katja Gagen, VP Marketing
Data that help doctors and life sciences companies improve patient care and reduce costs will be their most valuable asset in five years, according to a survey by PricewaterhouseCoopers. If so, then Boston-based Humedica, Inc. stands to be a big winner.
Reveal Imaging Technologies Inc. said it has signed a $14.3 million contract with a Mexican airport operator to install the company's explosives detection systems at five airports.
Last month was not at all about equality, at least when it came to venture investing. Overall, monthly venture investing totals have remained pretty stable for most of the spring in Massachusetts, hovering around the $200 million neighborhood, based on data provided by private company intelligence platform CB Insights. (That’s only counting deals worth $1 million and up; we’ll write about the sub-$1 million startup financings in a separate story.) The real news each month has been whether the investments have been distributed on a relatively egalitarian basis across sectors, or whether one particular industry has charged ahead to take the majority of venture dollars.
Hugh Herr can phone his ankles.
An associate professor at the MIT-Harvard Div. of Heath Sciences and Technology, he can do that because, after losing his legs 28 years ago, he refused to accept the state of the art in prosthetic technology.